SAN DIEGO, April 3, 2019 /PRNewswire/ — Epic Sciences, Inc. and its research partners today report the use of the company’s new circulating tumor cell (CTC) homologous recombination deficiency (HRD) liquid biopsy assay for the prediction of drug re… […]
SAN DIEGO and WETTEREN, Belgium, April 3, 2019 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Jean-Bapti… […]
Data Shows New Product Candidate, using both CXCL9 and anti-CD3 with Enhanced IL-12, Drives Strong Immune Response to Shrink TumorsData Shows Improved Electroporation Generator Greatly Enhances DNA-Plasmid-based Anti-tumor Regression in a Difficult to … […]
SAN DIEGO, April 1, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at the H.C. Wainwright & Co. Global Life Sciences Conference in London, England on Monday, April 8th at 1… […]
SAN DIEGO, April 1, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet… […]
NuVasive Expands Applications of Porous PEEK Surface Technology to Lateral Surgery with First-of-its-Kind Cohere® XLIF Implant
SAN DIEGO, April 1, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused… […]
Progress made implementing the Company’s commercial strategy highlighted by 7% sequential quarterly growth in billable test volume in the fourth quarter of 2018 compared to the third quarter of 2018Capitalized to deliver on key initiatives in 2019 incl… […]
LA JOLLA, Calif., March 26, 2019 /PRNewswire/ — CalciMedica, a clinical-stage biopharmaceutical company developing CM4620, a novel small molecule compound for acute pancreatitis, announced that A. Rachel Leheny, Ph.D., has joined its Board of Direc… […]
Expansion of Biocept’s EmpowerTC(TM) offering now includes predictive and prognostic biomarker testing to aid pathologists and urologists in the management of patients diagnosed with prostate cancer
SAN DIEGO, March 26, 2019 /PRNewswire/ — Biocept, … […]
CLAREMONT, Calif., March 25, 2019 /PRNewswire/ — Researchers have found multiple applications for the CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) gene editing technology since it came into use by the scientific community. Ke… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
